Across its top 20 institutional holders, AZN's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 10/100, avg. turnover score 26/100).

Quarterly Activity

Recent Activity

+$135.7B

Total Buy Value

$85.9M

Total Sell Value

New buy1243

Trim42

Add1

Sold out3

1244

Net Buyers

Net Sellers

Top Movers

AZN

Q1 2026

Top 5 Institutional Movers

Vanguard Group

Aggregated

+$15.2B

New buy

Investor AB

+$10.2B

New buy

Capital International Investors

+$6.7B

New buy

Fidelity

+$5.8B

New buy

Capital World Investors

+$5.5B

New buy

Data by AlphaSMO • Not financial advice.

Smart Money Convergence

AZN does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/AZN

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

G0593M107, 04634X103, 04635310 , 046353908, 046353958

FAQ

Who are the top institutional investors holding AstraZeneca PLC (AZN)?

Major stakeholders currently include Investor AB ($10.2B), Vanguard Capital Management LLC ($8.8B), Capital International Investors ($6.7B). Based on the latest 13F filings, there are a total of 1309 tracked investment funds and institutions maintaining positions in AZN.

What is the overall institutional sentiment toward AZN recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $132.0B, driven by 1244 managers accumulating shares while 45 reduced their exposure.

Which institutions have been selling or reducing their AZN positions?

In the latest period, 42 funds trimmed their holdings, and 3 managers completely exited their positions. The aggregate reported sell value was $85.9M.

Are there any notable investors adding AZN to their portfolios?

Yes, buying activity remains notable. 1243 institutions opened new positions in {ticker}, and 1 existing holders added to their shares. The total reported buy value for the quarter amounted to $135.7B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,605

Total reported value

$438.9B

1205 institutions currently hold both AZN and this stock

View detail

LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

1205 institutions currently hold both AZN and this stock

View detail

ABBV

Abbvie INC

Institutions Holding

4,029

Total reported value

$283.9B

1177 institutions currently hold both AZN and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access AZN's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/AZN

CLI

npx alphasmo stocks get AZN

Full API & MCP documentation →